Board of Directors

Bradley A. Connor, MD

Bradley A. Connor, M.D. is a clinical professor of medicine at the Weill Cornell Medical College and attending physician at the New York Presbyterian Hospital. He is founder and medical director of the New York Center for Travel and Tropical Medicine, a facility devoted to patient care, teaching, and research in Travel and Tropical medicine. Dr. Connor has been in the private practice of Gastroenterology, Infectious Diseases, and Tropical Medicine for the past 30 years. In addition to working as a subspecialist, Dr. Connor specializes in the evaluation of complex diagnostic problems and coordination of medical care across multiple medical disciplines.

His main research interests include chronic gastrointestinal disorders in returned travelers, emerging gastrointestinal pathogens, and emerging infectious disease surveillance. He was part of the Kathmandu, Nepal team that first described the clinical illness associated with Cyclospora infections and made subsequent contributions to the understanding of its pathogenesis, epidemiology, and treatment. Widely published in these fields, he is co-editor of the textbook Travel Medicine, now in its 4th edition. He is the author of over 200 peer reviewed medical publications and serves on the editorial boards or as a reviewer for over 25 medical journals.

Dr. Connor was the co-chair of the Centers for Disease Control and Prevention (CDC) sponsored Travelers’ Diarrhea Consensus Conference, held in April 2016. New guidelines for the diagnosis and management of Travelers’ Diarrhea were developed during this conference and the proceedings were published in April 2017. Dr. Connor is the author of the sections on Travelers’ Diarrhea and Persistent Diarrhea in the CDC Health Information for International Travel “Yellow Book” and CDC website.

Dr. Connor is past president of the International Society of Travel Medicine (ISTM), an organization of over 4000 physicians and allied health professionals in over 75 countries. He is a consultant to the Centers for Disease Control and Prevention (CDC) and has been part of the Health Information for International Travel working group in the Division of Global Migration and Quarantine since 1997. He is the New York City site director for GeoSentinel, the emerging infectious diseases network of the CDC and ISTM. He founded and is president of the GeoSentinel Foundation, a U.S. 501c3 not-for-profit charitable foundation devoted to support of global emerging infectious disease surveillance and research.  Dr. Connor played a role in the New York City Department of Health response to influenza H1N1 in 2009 and served as an advisor to the oil and gas industry around the Ebola virus outbreak in 2014. Dr. Connor was a member of the task force on Travel Medicine at the World Health Organization (WHO) in 2003. Dr. Connor has served as a consultant to the White House Medical Unit (WHMU) since 1999 and is an advisor in Travel Medicine for the U.S. Olympic Swim Team.

Dr. Connor has coordinated the medical care for President Bill Clinton and the Clinton family since 2001. Dr. Connor has also been the medical director for the Rolling Stones band since 2003, providing coordinated medical advance for their multi-city, multi-country and multi-continent tours. Utilizing the principles of VIP dignitary and performance medicine, Dr. Connor and his team of trained physicians has overseen the myriad medical issues which can arise in a group of musicians in their 70s and an entourage of over 75 individuals who travel on tour sometimes for months at a time. He has now extended his support of the entertainment industry by creating medical support and COVID mitigation programs for several other touring bands including Phil Collins and Genesis.

Dr. Connor is currently involved in activities related to the COVID-19 pandemic including development of a New York City based community SARS CoV-2 PCR testing laboratory. He developed research protocols for studies into treatment of SARS-CoV-2 patients as well as serving as principal investigator in a biomarker study to prognosticate outcome in newly diagnosed COVID patients. He has been providing pandemic response advice and counsel to several major corporations including Teneo for whom he served as a senior medical advisor, as well as Major League Soccer (MLS), Equinox, LionTree LLC, Rudin Management, the Professional Golf Association (PGA), Nima Capital, MTS Health Partners, Schulte, Roth & Zabel, LLC and the Writers Guild of America (WGA) with a focus on business continuity, mitigation measures, and return to work planning.

Dr. Connor received his medical degree from the University of Texas Southwestern Medical School in Dallas. He completed both his internship and residency in internal medicine at the University of Texas Health Science Center Hospitals in San Antonio and his fellowship in gastroenterology at the New York Hospital-Cornell University Medical College and Rockefeller University.

Dr. Connor is a Fellow of the American Gastroenterological Association (AGA-F), Fellow of the Infectious Disease Society of America (FIDSA) and was awarded Fellowship in the Royal College of Physicians and Surgeons (Glasgow) FFTM, FRCPS.

Get Updates from PHR